Sagimet Biosciences Inc. (SGMT)Healthcare | Biotechnology | San Mateo, United States | NasdaqGM
6.47 USD
+0.28
(4.523%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 6.47 +0.00 (0.002%) ⇧ (April 17, 2026, 7:51 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:28 p.m. EDT
SGMT is a highly volatile stock with a negative forward PE and earnings, indicating weak fundamentals. The recent price history shows a range-bound movement, with no clear upward trend. The lack of dividend payouts and weak financial metrics suggest it is not a suitable investment for either short-term or long-term strategies. The options market shows no clear consensus on the direction, making it a risky proposition for speculative trading. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.120212 |
| AutoETS | 0.121471 |
| AutoARIMA | 0.121472 |
| AutoTheta | 0.130513 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 58% |
| H-stat | 2.22 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.960 |
| Excess Kurtosis | -0.18 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.07 |
| Market Cap | 210,825,648 |
| Forward P/E | -3.39 |
| Beta | 3.21 |
| Website | https://www.sagimet.com |
As of April 11, 2026, 4:28 p.m. EDT: Options activity shows mixed signals. The ATM strikes are heavily positioned with high open interest and implied volatility, indicating potential for short-term price movements. However, the presence of significant OI in out-of-the-money strikes suggests speculation on both upward and downward trends. The overall volatility is moderate, but the lack of a clear directional bias makes it challenging to determine a strong short-term opportunity.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.5899582 |
| Address1 | 155 Bovet Road |
| Address2 | Suite 303 |
| All Time High | 20.71 |
| All Time Low | 1.73 |
| Ask | 6.63 |
| Ask Size | 3 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 346,580 |
| Average Daily Volume3 Month | 523,822 |
| Average Volume | 523,822 |
| Average Volume10Days | 346,580 |
| Beta | 3.212 |
| Bid | 6.37 |
| Bid Size | 3 |
| Book Value | 3.425 |
| City | San Mateo |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.47 |
| Current Ratio | 22.82 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 6.55 |
| Day Low | 6.27 |
| Debt To Equity | 0.07 |
| Display Name | Sagimet Biosciences |
| Earnings Timestamp | 1,773,232,200 |
| Earnings Timestamp End | 1,778,157,000 |
| Earnings Timestamp Start | 1,778,157,000 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 97,779,640 |
| Eps Current Year | -1.691 |
| Eps Forward | -1.907 |
| Eps Trailing Twelve Months | -1.58 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.3613 |
| Fifty Day Average Change | 1.1086998 |
| Fifty Day Average Change Percent | 0.20679682 |
| Fifty Two Week Change Percent | 158.99582 |
| Fifty Two Week High | 11.41 |
| Fifty Two Week High Change | -4.94 |
| Fifty Two Week High Change Percent | -0.43295357 |
| Fifty Two Week Low | 2.29 |
| Fifty Two Week Low Change | 4.18 |
| Fifty Two Week Low Change Percent | 1.8253275 |
| Fifty Two Week Range | 2.29 - 11.41 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,689,341,400,000 |
| Float Shares | 29,976,669 |
| Forward Eps | -1.907 |
| Forward P E | -3.3927634 |
| Free Cashflow | -30,215,624 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 16 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.06365 |
| Held Percent Institutions | 0.45011002 |
| Implied Shares Outstanding | 32,585,107 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,023-07-14 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California. |
| Long Name | Sagimet Biosciences Inc. |
| Market | us_market |
| Market Cap | 210,825,648 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_34541828 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -51,038,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 211,151,493 |
| Number Of Analyst Opinions | 9 |
| Open | 6.27 |
| Operating Cashflow | -45,650,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 650 561 8600 |
| Post Market Change | 0.0001001358 |
| Post Market Change Percent | 0.0015476941 |
| Post Market Price | 6.4701 |
| Post Market Time | 1,776,469,918 |
| Previous Close | 6.19 |
| Price Eps Current Year | -3.8261383 |
| Price Hint | 2 |
| Price To Book | 1.8890511 |
| Profit Margins | 0.0 |
| Quick Ratio | 22.177 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.3 |
| Region | US |
| Regular Market Change | 0.28 |
| Regular Market Change Percent | 4.52342 |
| Regular Market Day High | 6.55 |
| Regular Market Day Low | 6.27 |
| Regular Market Day Range | 6.27 - 6.55 |
| Regular Market Open | 6.27 |
| Regular Market Previous Close | 6.19 |
| Regular Market Price | 6.47 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 618,524 |
| Return On Assets | -0.25696 |
| Return On Equity | -0.38204 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 32,017,613 |
| Shares Percent Shares Out | 0.099 |
| Shares Short | 3,225,311 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 3,659,324 |
| Short Name | Sagimet Biosciences Inc. - Seri |
| Short Percent Of Float | 0.1084 |
| Short Ratio | 8.83 |
| Source Interval | 15 |
| State | CA |
| Symbol | SGMT |
| Target High Price | 35.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 25.77778 |
| Target Median Price | 27.0 |
| Total Cash | 113,124,000 |
| Total Cash Per Share | 3.472 |
| Total Debt | 78,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.58 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.8966 |
| Two Hundred Day Average Change | -0.42659998 |
| Two Hundred Day Average Change Percent | -0.061856568 |
| Type Disp | Equity |
| Volume | 618,524 |
| Website | https://www.sagimet.com |
| Zip | 94,402 |